Anadys Pharmaceuticals

�� / ��

��

Anadys Pharmaceuticals ��

News Update: Roth Capital Downgrades Anadys Pharmaceuticals to Hold from Buy

Shares of Anadys Pharma (ANDS) were flat in pre-market trading after the the company was reportedly downgraded to Hold from Buy at Roth Capital. The firm lowered its price target to $2 from $5 on company shares. ...

�� 01 �� 2012

Anadys Pharmaceuticals ��

Anadys Pharmaceuticals, Inc. (Anadys Pharmaceuticals, Inc.)

www.anadyspharma.com

Anadys ��, Inc �� .

��

��
�� �� �� �� �� �� ��	�� �� �� �� �� ��

��
�� / �� / �� ��. �� �� �� ��. � �� . �� ��	�� �� ��, �� �� / �� �� �� ��

��
�� �� �� �� �� �� ��	�� �� �� �� �� �� ��

�� | ��

Anadys Pharmaceuticals

���������� � ��������

News Update: Roth Capital Downgrades Anadys Pharmaceuticals to Hold from Buy

��